The BioCentury London index rose 62% in 2013, while the BioCentury Europe index ended the year up 39%. The market cap-weighted London benchmark was swayed by a 91% increase in the value of BTG plc (LSE:BTG) to £2.1 billion ($3.4 billion) in 2013